Applying a similar approach to assess PAK2 high-expression cells and PAK2 low-expression cells, we observed that PAK2 triggered the upregulation of 17 metabolic pathways and the downregulation of 25 metabolic pathways in pancreatic cancer cells. The gene discussed is PAK2; the disease is familial pancreatic carcinoma.